Literature DB >> 21757932

Intravenous and peritonsillar infiltration of ketamine for postoperative pain after adenotonsillectomy: a randomized placebo-controlled clinical trial.

Saeed Khademi1, Fariborz Ghaffarpasand, Hamid Reza Heiran, Mohammad Javad Yavari, Siavash Motazedian, Maryam Dehghankhalili.   

Abstract

OBJECTIVE: To evaluate the efficacy of preoperative intravenous or peritonsillar infiltration of ketamine for postoperative pain control in children following adenotonsillectomy. PATIENTS AND METHODS: 78 children between 5 and 18 years of age who were scheduled for elective adenotonsillectomy were randomly assigned to four groups: group 1 (n = 19) received intravenous ketamine (0.5 mg/kg), group 2 (n = 21) intravenous normal saline, group 3 (n = 19) ketamine (0.5 mg/kg) injected through the tonsillar capsule, and group 4 (n = 19) normal saline injected in the same location. The incidence of postoperative pain and vomiting as well as the severity of postoperative pain were compared between study groups during the 6-hour postoperative period using a visual analog scale (VAS) at rest, upon swallowing saliva, drinking liquids and eating ice cream.
RESULTS: There were no demographic differences between the four groups. The incidence of postoperative pain was significantly lower in groups 1 [7 (36.8%) vs. 10 (47.6%); p = 0.032] and 3 [5 (31.5%) vs. 12 (63.2%); p = 0.001] compared with their controls. The amount (in milligrams) of pethidine and metoclopramide used for pain and nausea control was significantly lower in groups 1 (12.5 ± 5.3 vs. 19.6 ± 9.6 mg, p = 0.038, and 2.9 ± 1.1 vs. 4.6 ± 2.6 mg, p = 0.042, respectively) and 3 (8.6 ± 3.1 vs. 21.6 ± 8.4 mg, p < 0.001, and 1.6 ± 0.9 vs. 5.3 ± 3.2 mg, p = 0.002, respectively) compared with their controls. These values were also higher in group 1 compared with group 3. The VAS scores on swallowing saliva (3.9 ± 2.7 vs. 2.7 ± 1.2; p = 0.018), on drinking liquids (3.7 ± 2.6 vs. 2.8 ± 1.6; p = 0.013) and on eating ice-cream (4.3 ± 2.4 vs. 2.8 ± 1.5; p = 0.001) were also significantly higher in group 1 compared with group 3.
CONCLUSIONS: Our results show that peritonsillar infiltration of ketamine was more effective in reducing the postoperative pain severity, need for analgesics and need for antiemetics. Thus, peritonsillar infiltration of ketamine is suggested for postoperative pain control in those undergoing adenotonsillectomy.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757932     DOI: 10.1159/000327657

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  5 in total

1.  Treatment effects of dexmedetomidine and ketamine on postoperative analgesia after cleft palate repair.

Authors:  Talal A Kayyal; Erik M Wolfswinkel; William M Weathers; Samantha J Capehart; Laura A Monson; Edward P Buchanan; Chris D Glover
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-02-28

2.  Analgesia for adenotonsillectomy in children: a comparison between peritonsillar infiltration of tramadol, ketamine, and placebo.

Authors:  Juliana Alves de Sousa Caixeta; Jessica Caixeta Silva Sampaio; Paulo Sergio Sucasas da Costa; Melissa Ameloti Gomes Avelino
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-10       Impact factor: 2.503

3.  Ketamine administration makes patients and physicians satisfied during gastro-enteric endoscopies.

Authors:  Saeed Majidinejad; Abdollah Kajbaf; Mahsa Khodadoostan; Shahaboddin Dolatkhah; Mohammad Hossein Kajbaf; Peiman Adibi; Maryam Malekmohammad
Journal:  J Res Med Sci       Date:  2015-09       Impact factor: 1.852

4.  Efficacy of ketamine in improving pain after tonsillectomy in children: meta-analysis.

Authors:  Hye Kyung Cho; Kyu Won Kim; Yeon Min Jeong; Ho Seok Lee; Yeon Ji Lee; Se Hwan Hwang
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

5.  Thoracic paravertebral block for postoperative pain management in percutaneous nephrolithotomy patients: a randomized controlled clinical trial.

Authors:  K Ak; S Gursoy; C Duger; A C Isbir; K Kaygusuz; I Ozdemir Kol; G Gokce; C Mimaroglu
Journal:  Med Princ Pract       Date:  2012-12-14       Impact factor: 1.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.